Intraoperative floppy iris syndrome is a clinical situation encountered during phacoemulsification characterized by loss of iris muscle tone, predominantly seen in patients on alpha-1 receptor antagonist medication.The floppiness of the iris tissue alo…
DefEYE launches as independent company
DefEYE Inc., previously a subsidiary of Verséa Health operating as Verséa Ophthalmics, announced its launch as an independent company, according to a press release.DefEYE launched with a portfolio of decellularized biologics, including Biovance 3L Ocul…
Broadwood Partners Publishes Presentation Detailing Opposition to STAAR Surgical’s Sale to Alcon
NEW YORK–(BUSINESS WIRE)–Broadwood Partners, L.P. and its affiliates (collectively, “Broadwood”), holders of approximately 27.5% of the outstanding common stock of STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA), today announced that…
Long-Term Control of NMOSD With Ravulizumab
For neuromyelitis optica spectrum disorder, long-term follow-up with a second-generation complement inhibitor shows an unprecedented level of disease control at 3 years. Medscape Medical News
Perfect Corp. Releases Virtual Try-On for Glasses Update with New In-Platform Product Library Featuring Over 13,000 Pre-Loaded Glasses SKUs
NEW YORK–(BUSINESS WIRE)–Perfect Corp., the leading AI and AR beauty and fashion technology provider and developer of ‘Beautiful AI’ solutions, proudly announces a major update to its Online Service for Virtual Glasses Try-On. The new feature introdu…
Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
WALTHAM, Mass.–(BUSINESS WIRE)–Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biopharmaceutical company focused on discovering, developing, and commercializing potential best-in-class medicines for serious and rare diseases, today announced that the C…